Pawar Vishal, Ashraf Hanaan, Dorsala Srinivas, Mary Preethy, Hameed Nazrin, H Divya Nair, Adatia Sweta Prakash, Raj Leya, Ananthu V R, Shouka M
Neurology Department, Aster Gardens Specialty Clinic, Building 10, Zen Cluster, Street 1, Discovery Gardens, Dubai P.O. Box 8703, United Arab Emirates.
Al Rafa Polyclinic-International City, Internal Medicine Department, Aster DM Healthcare, Dubai P.O. Box 8703, United Arab Emirates.
J Pers Med. 2023 Apr 26;13(5):732. doi: 10.3390/jpm13050732.
Motorist's vestibular disorientation syndrome (MVDS) is a disorder in which patients experience dizziness while driving. MVDS is under-reported in the literature, and in clinical practice, it often goes unrecognized. We identified clinical characteristics of patients with MVDS using data from 24 patients who faced difficulties while driving and were diagnosed with MVDS. Their symptoms, duration of illness, precipitating factors, co-morbidities, history of other neuro-otological disorders, severity of symptoms, and associated anxiety and depression were reviewed. Ocular motor movements were recorded using video-nystagmography. Patients with vestibular disorders that can cause similar symptoms while driving were excluded. The mean age of the patients was 45.7 ± 8.7 years, and most were professional drivers (90.5%). The duration of the illness ranged from eight days to ten years. Most patients presented with disorientation (79.2%) exclusively while driving. The most common triggers for symptoms were higher speeds, i.e., >80 km/h (66.7%), multi-lane roads (58.3%), bends and turns (50%), and looking at other vehicles or signals while driving (41.7%). A history of migraines was reported in 62.5% of the patients, and motion sickness was reported in 50% of the patients. Anxiety was reported in 34.3% of patients, and 15.7% had depression. The video-nystagmography did not show any specific abnormalities. Patients responded to drugs used in prophylactic treatments for migraines such as Amitriptyline, Venlafaxine, Bisoprolol, and Magnesium, and to Pregabalin and Gabapentin. Based on these findings, a classification system and a diagnostic criterion for MVDS were proposed.
驾驶员前庭定向障碍综合征(MVDS)是一种患者在驾驶时会感到头晕的疾病。MVDS在文献中的报道较少,在临床实践中也常常未被识别。我们利用24例在驾驶时遇到困难并被诊断为MVDS的患者的数据,确定了MVDS患者的临床特征。对他们的症状、病程、诱发因素、合并症、其他神经耳科疾病史、症状严重程度以及相关的焦虑和抑郁情况进行了回顾。使用视频眼震图记录眼球运动。排除了在驾驶时可引起类似症状的前庭疾病患者。患者的平均年龄为45.7±8.7岁,大多数是职业驾驶员(90.5%)。病程从8天到10年不等。大多数患者仅在驾驶时出现定向障碍(79.2%)。症状最常见的触发因素是较高的车速,即>80公里/小时(66.7%)、多车道道路(58.3%)、弯道和转弯处(50%)以及驾驶时看其他车辆或信号(41.7%)。62.5%的患者报告有偏头痛病史,50%的患者报告有晕动病。34.3%的患者报告有焦虑,15.7%的患者有抑郁。视频眼震图未显示任何特定异常。患者对用于偏头痛预防性治疗的药物如阿米替林、文拉法辛、比索洛尔和镁,以及普瑞巴林和加巴喷丁有反应。基于这些发现,提出了MVDS的分类系统和诊断标准。